American Century Companies Inc Collegium Pharmaceutical, Inc Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, American Century Companies Inc holds 104,913 shares of COLL stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,913

Previous 99,808 5.11%

Holding current value

$3.15 Million

Previous $3.21 Million 26.14%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $160,297 - $199,452	5,105 Added 5.11%	104,913 $4.05 Million
Q2 2024 Aug 07, 2024	BUY	$31.36 - $39.99 $253,921 - $323,799	8,097 Added 8.83%	99,808 $3.21 Million
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $689,089 - $902,679	22,065 Added 31.68%	91,711 $3.56 Million
Q4 2023 Feb 13, 2024	BUY	$21.16 - $30.8 $1.47 Million - $2.15 Million	69,646 New	69,646 $2.14 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $148,567 - $169,911	6,998 Added 17.72%	46,480 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $272,916 - $311,016	12,959 Added 48.86%	39,482 $848,000
Q1 2023 May 11, 2023	BUY	$23.0 - $29.88 $610,029 - $792,507	26,523 New	26,523 $636,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $614,705 - $799,196	-39,761 Reduced 53.15%	35,049 $561,000
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $767,453 - $1.13 Million	-53,970 Reduced 41.91%	74,810 $1.33 Million
Q1 2022 May 11, 2022	BUY	$17.2 - $22.5 $460,272 - $602,100	26,760 Added 26.23%	128,780 $2.62 Million
Q4 2021 Feb 07, 2022	BUY	$17.5 - $21.35 $335,247 - $409,001	19,157 Added 23.12%	102,020 $1.91 Million
Q3 2021 Nov 10, 2021	BUY	$17.75 - $25.39 $218,715 - $312,855	12,322 Added 17.47%	82,863 $1.64 Million
Q2 2021 Aug 05, 2021	BUY	$21.74 - $25.28 $386,645 - $449,604	17,785 Added 33.71%	70,541 $1.67 Million
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $42,812 - $58,046	2,224 Added 4.4%	52,756 $1.25 Million
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $185,806 - $232,284	10,421 Added 25.98%	50,532 $1.01 Million
Q3 2020 Nov 13, 2020	BUY	$15.78 - $20.82 $180,665 - $238,368	11,449 Added 39.94%	40,111 $835,000
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $207,318 - $314,657	-13,384 Reduced 31.83%	28,662 $502,000
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $584,018 - $1.07 Million	42,046 New	42,046 $687,000
Q3 2019 Nov 13, 2019	SELL	$10.16 - $13.28 $1.98 Million - $2.59 Million	-195,076 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $376,903 - $588,779	35,490 Added 22.24%	195,076 $2.57 Million
Q1 2019 May 14, 2019	BUY	$13.58 - $18.72 $1.44 Million - $1.98 Million	105,757 Added 196.47%	159,586 $0
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $795,592 - $1.06 Million	53,829 New	53,829 $924,000

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Collegium Pharmaceutical, Inc Transaction History